![4-(5-{[(3-苯基-1,2,4-噁二唑-5-基)甲基]硫烷基}-1,3,4-噁二唑-2-基)吡啶, 919936-70-2, 结构式](https://yunshiji.oss-cn-shenzhen.aliyuncs.com/202411/03/0012328218800000201.gif)
|
|
4-(5-{[(3-苯基-1,2,4-噁二唑-5-基)甲基]硫烷基}-1,3,4-噁二唑-2-基)吡啶
|
|
- CAS号:
- 919936-70-2
- 英文名:
- 4-(5-{[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]sulfanyl}-1,3,4-oxadiazol-2-yl)pyridine
- 英文别名:
- GS87;4-[5-[[(3-Phenyl-1,2,4-oxadiazol-5-yl)methyl]thio]-1,3,4-oxadiazol-2-yl]pyridine;3-Phenyl-5-(((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)methyl)-1,2,4-oxadiazole;Pyridine, 4-[5-[[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]thio]-1,3,4-oxadiazol-2-yl]-;4-(5-{[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]sulfanyl}-1,3,4-oxadiazol-2-yl)pyridine;GS-87,GSK3α,GSK-3,Inhibitor,Glycogen synthase kinase 3,MAPK,GS 87,inhibit,Glycogen synthase kinase-3,GSK3,GS87,AML,differentiation,GSK3β
- 中文名:
- 4-(5-{[(3-苯基-1,2,4-噁二唑-5-基)甲基]硫烷基}-1,3,4-噁二唑-2-基)吡啶
- 中文别名:
- 化合物GS87;3-苯基-5-(((5-(吡啶-4-基)-1,3,4-恶二唑-2-基)硫基)甲基)-1,2,4-恶二唑;4-(5-{[(3-苯基-1,2,4-噁二唑-5-基)甲基]硫烷基}-1,3,4-噁二唑-2-基)吡啶
- CBNumber:
- CB08143017
- 分子式:
- C16H11N5O2S
- 分子量:
- 337.36
- MOL File:
- 919936-70-2.mol
|
|
|
VIP会员
400-6226-992
粤公网安备44196802000105号
